Screening for Down syndrome by analyzing cell-free DNA (cfDNA) in maternal blood has a higher detection rate and lower false-positive rate than other screening approaches, the authors of a new meta-analysis conclude.
Reuters Health Information …read more
Nice posts! 🙂
___
Sanny